CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Wuhan King Diagnostic Technology Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Wuhan King Diagnostic Technology Co Ltd
Phone: +86 2787531712p:+86 2787531712 WUHAN, HUB  430206  China Fax: +86 2787531713f:+86 2787531713
Business Summary
Wuhan King Diagnostic Technology Co Ltd is mainly engaged in the research and development, production and sales of in vitro diagnostic products. The Company's main products are in-vitro testing equipment and in-vitro diagnostic substance products. The in-vitro testing equipments contain TD-III specific protein, fully automatic C-reactive protein analyzer, GDC series blood coagulation analyzer and others; the in-vitro diagnostic substance products include lipoprotein (a) [LP (a)] assay kit and D- two poly (D-Dimer) assay kit, among others.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/201312/31/2013Yes----

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
5122 Drugs, drug proprietaries, and druggists' sundries

General Information
Outstanding Shares: 6,250,000 (As of 12/31/2013)
Fax Number: +86 2787531713


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 10, 2023